Perceptive Advisors LLC Biogen Inc. Transaction History

Perceptive Advisors LLC

  • $3.46 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$193.77 - $244.14 $9.42 Million - $11.9 Million
-48,600 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $13.8 Million - $17.9 Million
48,600 New
48,600 $13.8 Million
Q2 2018

Aug 14, 2018
SELL
$257.52 - $306.91 $5.15 Million - $6.14 Million
-20,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$260.13 - $367.91 $5.2 Million - $7.36 Million
20,000 New
20,000 $5.48 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email